Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs Lam Research Corporation (LRCX) Price & Performance

Direxion Daily CSI China Internet Bull 2X SharesTrade
Lam Research CorporationTrade

Price performance (Past 24H)

Key statistics

Direxion Daily CSI China Internet Bull 2X Shares vs Lam Research Corporation — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.2 (market cap $173.62M), while Lam Research Corporation trades at $326.99 (market cap $401.19B). The key difference: Lam Research Corporation is far larger — about 2310.7× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Lam Research Corporation pays a 0.41% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Lam Research Corporation for 60 Days on average.

CWEBLRCX
Market Cap
$173.62M$401.19B
Volume
551,7268,960,892
Sector
Leveraged / InverseTechnology
52-Week High
$55.62$433.33
52-Week Low
$17.39$131.37
Typical Hold Time
24 Days60 Days
Enterprise Value
—$399.35B
Dividend Yield
—0.41%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily CSI China Internet Bull 2X Shares

CWEB is trading at $18.02, down 1.85% on the day, with technical indicators showing a bearish trend across moving averages. The stock faces selling pressure with all 13 moving average signals bearish and key resistance levels clustered around $18. Recent news highlights China's AI ambitions and potential growth in China tech stocks as catalysts.

The outlook remains cautious due to technical weakness, though exposure to China's growing AI sector offers long-term potential. Key risks include China market volatility and competitive pressures. Investors should monitor earnings reports for fundamental validation of growth prospects.

Lam Research Corporation

Lam Research (LRCX) trades at $329.51, down 1.31% on the day, amid a bullish technical setup with strong support at $326 and resistance at $332. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.82 exceeding the $1.69 estimate. Revenue growth accelerated to $18.44B in 2025, driving a net income margin of 31.27%. Analyst sentiment remains overwhelmingly positive, with 78% recommending Buy and a consensus price target of $375.68, suggesting significant upside potential from current levels.

LRCX is well-positioned to capitalize on AI-driven demand for semiconductor equipment, supported by expanding margins and strong cash flow. However, elevated valuation multiples (P/E of 57.21) and exposure to cyclical chip industry downturns pose risks. The stock offers growth appeal for investors bullish on sustained tech capex, but requires monitoring of competitive pressures and macroeconomic headwinds that could impact equipment spending.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CWEB
100% Buy0% Sell
Avg holding period · 24 Days
LRCX
67% Buy33% Sell
Avg holding period · 60 Days

Top news

Latest headlines on both assets

About Direxion Daily CSI China Internet Bull 2X Shares

CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.

Read more on CWEB →

About Lam Research Corporation

Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.

Read more on LRCX →